Scientific Research An Academic Publisher
OPEN ACCESS
Rituximab Improves Overall Survival in Patients Treated with CODOX-M/IVAC for Burkitt Lymphoma (BL) and B-Cell Lymphoma, Unclassifiable, with Features Intermediate between Diffuse Large B-Cell Lymphoma and BL (BCL-U): A Single Center Experience and Review of the Literature (Articles)
A. Prica, A. Pratzer, M. Cheung, K. Thompson, E. Piliotis, N. L. Berinstein, K. Imrie, R. Pradhan, A. Vyas, Z. Ghorab, D. Good, L. Zhang, R. Buckstein
Journal of Cancer Therapy Vol.6 No.1,December 26, 2014
DOI: 10.4236/jct.2015.61001 3,721 Downloads 4,521 Views Citations This article belongs to the Special Issue on Advances in Lymphoma Research